TriVascular, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in innovative vascular solutions, particularly in the treatment of abdominal aortic aneurysms (AAAs). TriVascular's flagship product, the Ovation® Abdominal Stent Graft System, is renowned for its unique design that enhances patient outcomes through a minimally invasive approach. With a strong presence in North America and expanding operations in Europe, TriVascular is committed to advancing vascular health. The company has achieved significant milestones, including regulatory approvals and successful clinical trials, solidifying its market position. TriVascular continues to focus on developing cutting-edge technologies that address the evolving needs of healthcare professionals and patients alike.
We don't have data for TriVascular, Inc., but we can show you information about their parent organization instead.
View parent company